Study to Determine the Difference in Reduction of Bioaerosols in a Long-term Care Facility
NCT ID: NCT06506890
Last Updated: 2024-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
100 participants
INTERVENTIONAL
2024-09-05
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Air Purifiers in Classrooms for Infection Control - a Pilot Study
NCT06374316
BC Women's Hospital Noise Pilot
NCT02651129
Preventing Respiratory Viral Illness Invisibly
NCT05084898
Effect of Aerosol Filtering on Infectious Diseases in Day Care
NCT05569330
Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial
NCT00563186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Endpoint:
This study aims to determine the reduction of bioaerosols (BAMS) in a facility with a C-POLAR HVAC filter building intervention versus conventional filters.
Secondary Endpoints:
1. Volatile organic compound (VOC)
2. Radon determination
3. Static, passive particulate determination from air
4. Air microbiome analysis
5. Air Quality and Respiratory Staff Survey
Radon gas testing, particulate matter testing (PM2.5) \[fine inhalable particles, with diameters that are generally 2.5 micrometers and smaller\]. Carbon dioxide testing (CO2), VOCs testing \[volatile organic compounds (airborne chemicals)\], relative humidity (RH) testing \[it is a measure of the actual amount of water vapor in the air compared to the total amount of vapor that can exist in the air at its current temperature\], and temperature readings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
comparing the difference in reduction of bioaerosols between HVAC filters
comparing the difference in reduction of bioaerosols between HVAC filters.
Use of C-Polar coated HVAC Filter versus conventional HVAC Filter
comparing the difference in reduction of bioaerosols between HVAC filters.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of C-Polar coated HVAC Filter versus conventional HVAC Filter
comparing the difference in reduction of bioaerosols between HVAC filters.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kelowna General Hospital
OTHER_GOV
C-Polar Innovations
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deanne Taylor, PhD
Role: PRINCIPAL_INVESTIGATOR
Kelowna General Hospital
Michael Mansour, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Harvard Medical School (HMS and HSDM)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kelowna General Hospital
Kelowna, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zachary Walbaum, MHE, MPhil
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H23-04137
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.